(NTLA) Intellia Therapeutics - Performance -64% in 12m
Compare NTLA with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
-57.23%
#76 in Group
Rel. Strength
7.40%
#7368 in Universe
Total Return 12m
-64.00%
#129 in Group
Total Return 5y
-46.89%
#54 in Group
P/E -
(?) Percentile in Group
P/E Forward -
(?) Percentile in Group
PEG -0.10
50th Percentile in Group
FCF Yield -77.82%
(?) Percentile in Group
12m Total Return: NTLA (-64%) vs XBI (-12.3%)
5y Drawdown (Underwater) Chart
Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| UTHR NASDAQ United Therapeutics |
10.1% | 18% | 166% | 12.1 | 11 | 1.43 | 74.6% | 16.1% |
| HLN NYSE Haleon |
14.3% | 31.2% | 47% | 24.4 | 20.2 | 1.79 | 69.1% | 13.6% |
| AMGN NASDAQ Amgen |
-2.93% | -8.78% | 30.7% | 25.5 | 13.5 | 0.95 | 0.60% | 41% |
| LONN SW Lonza |
9.55% | 9.34% | 30.4% | 67.1 | 35.1 | 1.28 | 2.20% | -12.5% |
| BIM PA Biomerieux |
0.78% | 17.8% | -2.14% | 32.5 | 25.2 | 1.52 | -38.5% | -25.1% |
| KMDA NASDAQ Kamada |
21.4% | 25.3% | -4.13% | 26.6 | 23.9 | 0.96 | 32.5% | 3.93% |
| NBIX NASDAQ Neurocrine Biosciences |
34.3% | -15.5% | 3.48% | 32.3 | 21.6 | 0.27 | 68.0% | 31.9% |
| ERF PA Eurofins Scientific SE |
20.4% | -0.39% | 7.63% | 26.6 | 13.6 | 0.56 | -66.6% | -17.1% |
Performance Comparison: NTLA vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for NTLA
| Total Return (including Dividends) | NTLA | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 31.85% | 11.81% | 13.81% |
| 3 Months | -13.57% | -13.61% | -6.30% |
| 12 Months | -64.00% | -12.29% | 10.65% |
| 5 Years | -46.89% | -24.89% | 107.77% |
| Trend Score (consistency of price movement) | NTLA | XBI | S&P 500 |
| 1 Month | 56.7% | 72.9% | 83% |
| 3 Months | -76.9% | -83% | -75.3% |
| 12 Months | -96.1% | -51.6% | 50.1% |
| 5 Years | -53.0% | -53.9% | 84.1% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
| 1 Month | #37 | 17.9% | 15.9% |
| 3 Month | #72 | 0.05% | -7.76% |
| 12 Month | #129 | -59.0% | -67.5% |
| 5 Years | #55 | -29.3% | -74.4% |
FAQs
Does NTLA Intellia Therapeutics outperforms the market?
No,
over the last 12 months NTLA made -64.00%, while its related Sector, the SPDR S&P Biotech (XBI) made -12.29%.
Over the last 3 months NTLA made -13.57%, while XBI made -13.61%.
Over the last 3 months NTLA made -13.57%, while XBI made -13.61%.
Performance Comparison NTLA vs Indeces and Sectors
NTLA vs. Indices NTLA is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -5.35% | 18.0% | -45.6% | -74.7% |
| US NASDAQ 100 | QQQ | -5.54% | 14.5% | -45.8% | -75.6% |
| US Dow Jones Industrial 30 | DIA | -5.76% | 21.9% | -45.3% | -71.7% |
| German DAX 40 | DAX | -5.33% | 16.9% | -71.8% | -89.7% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -7.53% | 20.0% | -46.3% | -71.4% |
| Hongkong Hang Seng | HSI | -8.52% | 11.9% | -53.9% | -77.7% |
| India NIFTY 50 | INDA | -0.43% | 27.0% | -46.0% | -63.8% |
| Brasil Bovespa | EWZ | -6.40% | 14.6% | -54.3% | -55.7% |
NTLA vs. Sectors NTLA is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -5.99% | 18.4% | -52.6% | -85.6% |
| Consumer Discretionary | XLY | -5.73% | 17.6% | -44.6% | -78.3% |
| Consumer Staples | XLP | -4.49% | 25.3% | -52.5% | -73.1% |
| Energy | XLE | -5.17% | 25.1% | -39.0% | -54.5% |
| Financial | XLF | -6.45% | 18.3% | -52.7% | -86.4% |
| Health Care | XLV | -2.34% | 31.0% | -40.6% | -59.9% |
| Industrial | XLI | -7.04% | 15.0% | -47.0% | -75.0% |
| Materials | XLB | -5.15% | 18.3% | -40.7% | -58.8% |
| Real Estate | XLRE | -4.03% | 20.3% | -46.3% | -79.5% |
| Technology | XLK | -6.43% | 10.6% | -42.7% | -71.1% |
| Utilities | XLU | -5.40% | 22.3% | -53.2% | -81.5% |
| Aerospace & Defense | XAR | -7.33% | 10.7% | -57.1% | -91.3% |
| Biotech | XBI | 1.24% | 20.0% | -25.4% | -51.7% |
| Homebuilder | XHB | -5.82% | 20.4% | -32.4% | -56.5% |
| Retail | XRT | -7.25% | 17.2% | -41.3% | -62.5% |